scispace - formally typeset
A

Amin Aghaebrahim

Researcher at Baptist Health

Publications -  107
Citations -  5984

Amin Aghaebrahim is an academic researcher from Baptist Health. The author has contributed to research in topics: Stroke & Modified Rankin Scale. The author has an hindex of 23, co-authored 83 publications receiving 4067 citations. Previous affiliations of Amin Aghaebrahim include Baptist Health System & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

TL;DR: Among patients with acute stroke who had last been known to be well 6 to 24 hours earlier and who had a mismatch between clinical deficit and infarct, outcomes for disability at 90 days were better with thrombectomy plus standard care than with standard care alone.
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.
Journal ArticleDOI

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Bruce C.V. Campbell, +1296 more
- 01 Jan 2019 - 
TL;DR: Estimated ischaemic core volume was independently associated with functional independence and functional improvement but did not modify the treatment benefit of endovascular thrombectomy over standard medical therapy for improved functional outcome.
Journal ArticleDOI

Final Infarct Volume Is a Stronger Predictor of Outcome Than Recanalization in Patients With Proximal Middle Cerebral Artery Occlusion Treated With Endovascular Therapy

TL;DR: In this series, age and final infarct volume but not recanalization were found to be independent predictors of outcome, supporting the use of final infArct volume as surrogate marker of outcome in acute stroke trials.